Post-earnings recap
Reported
Wed, Apr 22, 2026
EPS actual
$12.58
EPS est.
$10.68
EPS surprise
+17.75%
1-day move
+0.03%
Elevance Health's strong EPS performance indicates effective cost management and operational efficiency. The stock's slight increase of 0.03% reflects investor confidence in the company's ability to maintain profitability, despite the lack of revenue data and guidance. Overall, the results suggest a stable outlook for the company in the near term.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $12.58 | N/A | +17.75% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to operational efficiency. They did not provide specific guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining operational efficiency.
Elevance Health Inc (ELV) is a major player in the managed health care sector, providing health insurance and related services. With a market cap of $71 billion, the company is significant in shaping health care access and affordability, especially as the industry navigates regulatory changes and rising consumer demand for health services.
Last quarter
In Q4 2025, Elevance Health reported an EPS of $3.33, exceeding expectations by 7.28%. The stock reacted positively, gaining 5.86% the following day.
EPS beat streak
4Q
EPS beat rate
63%
Avg EPS surprise
+6.04%
Avg 1-day reaction
-2.71%
Overall, analysts are cautiously optimistic about Elevance Health's upcoming earnings, given their recent performance. However, uncertainty remains due to the lack of specific guidance.
Bull case
If Elevance can demonstrate strong membership growth and maintain a favorable medical loss ratio, it could signal robust demand and operational efficiency, leading to a positive market reaction.
Bear case
Conversely, if the company reports disappointing membership numbers or a high medical loss ratio, it could raise concerns about profitability and market competitiveness, leading to a negative reaction.
The print will turn on these.
Q1
What is the growth rate of membership this quarter?
Membership growth is crucial for revenue and indicates the company's competitive position in the market.
Q2
What is the current medical loss ratio?
A high medical loss ratio could signal potential profitability issues, which investors will closely watch.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Why consensus could be wrong
The Street may underestimate the impact of recent health care reforms that could drive membership growth higher than expected.
Supporting evidence
Recent trends in health care spending suggest increased demand for managed care services.
Elevance's recent performance shows a strong ability to adapt to market changes, which may not be fully reflected in current estimates.
Key risk
If membership growth exceeds 5%, it could challenge current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on membership growth and the medical loss ratio, both critical indicators of Elevance's operational health.
Bull confirmed if
Membership growth of 5% or more compared to the previous quarter would confirm the bull case.
Bear confirmed if
A medical loss ratio exceeding 85% would confirm the bear case.
What the market is pricing for the move.
Implied Move
±3.1%
Historical Avg
±5.4%
The options market is pricing in a modest move of around 3.1%, suggesting that traders expect limited volatility around the earnings report.
Options are pricing ±3.1% while ELV has averaged ±5.4% over the last 8 prints — setup is pricing cheap.
30d HV
24.7%
Smart-money positioning from the most recent 13F filings.
Institutional
94.13%
of float
Insider
0.19%
of float
Holders
2,159
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
18,991,090 sh · $7.7B
8.76%
-4.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Elevance beats expectations, history suggests the stock could rise by an average of 1.17%, confirming strong operational performance.
In line / cautious
If results are in line but management provides cautious commentary, the stock may see muted movement as investors digest the outlook.
Miss
A miss could lead to a decline of around 11.40%, reflecting investor disappointment and concerns over future growth.
The lines on the call that would change the story.
Vanguard Capital Management LLC
14,058,204 sh · $5.7B
6.48%
-2.0%
State Street Corporation
10,426,610 sh · $4.2B
4.81%
1.3%
Wellington Management Group, LLP
9,213,513 sh · $3.7B
4.25%
12.0%
Vanguard Portfolio Management LLC
6,214,356 sh · $2.5B
2.87%
-2.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.